The effectiveness of “Sputnik V” against the omicron-strain will be studied in three weeks

Head of RDIF: Sputnik V has shown high efficiency against all existing mutations the strain will take three weeks. This is reported by TASS with reference to an interview with the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev on CNBC.

Sputnik has shown incredibly high efficiency against all existing mutations. We believe that it will take three weeks to fully assess [the effectiveness of the vaccine against omicron], “TASS quoted him as saying.

Dmitriev also expressed confidence in the possibility of adapting the vaccine for all existing variants of the virus.

< p> Earlier, Dmitriev announced his readiness to create one hundred million booster doses of the Sputnik V vaccine adapted against the omicron strain in February 2022. At the same time, the Gamaleya Institute and RDIF announced their readiness to begin mass production of the vaccine by mid-January.

The strain under the code B.1.1.529 (omicron) was first identified in South Africa on November 11. Since the 28th, Russia has limited air traffic with several countries in the region, which is why Russian tourists are stuck in it. The issue of introducing a lockdown or any other restrictions due to the appearance of the omicron strain on the territory of the country requires a thorough study of the new version of the infection, the State Duma said.



Leave a Reply